Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth (Status and Outlook) 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of AI to Novel Coronavirus (COVID-19) and Epidemic will have significant change from previous year. By the most conservative estimates of global AI to Novel Coronavirus (COVID-19) and Epidemic market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the AI to Novel Coronavirus (COVID-19) and Epidemic market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of AI to Novel Coronavirus (COVID-19) and Epidemic market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the AI to Novel Coronavirus (COVID-19) and Epidemic, covering the supply chain analysis, impact assessment to the AI to Novel Coronavirus (COVID-19) and Epidemic market size growth rate in several scenarios, and the measures to be undertaken by AI to Novel Coronavirus (COVID-19) and Epidemic companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
AI Tracking
AI Predict
AI Recognition
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Medical
Public Emergency
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Google
Iktos
Alibaba
BlueDot
Beijing Infervision Technology Co., Ltd.
Artificial Intelligence in Medical Epidemiology
Insilico Medicine
BenevolentAI
DEARGEN
SenseTime
SRI Biosciences
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global AI to Novel Coronavirus (COVID-19) and Epidemic market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of AI to Novel Coronavirus (COVID-19) and Epidemic market by identifying its various subsegments.
Focuses on the key global AI to Novel Coronavirus (COVID-19) and Epidemic players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the AI to Novel Coronavirus (COVID-19) and Epidemic with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of AI to Novel Coronavirus (COVID-19) and Epidemic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the AI to Novel Coronavirus (COVID-19) and Epidemic?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2015-2025
2.1.2 AI to Novel Coronavirus (COVID-19) and Epidemic Market Size CAGR by Region
2.2 AI to Novel Coronavirus (COVID-19) and Epidemic Segment by Type
2.2.1 AI Tracking
2.2.2 AI Tracking
2.2.3 AI Recognition
2.2.4 Other
2.3 AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type
2.3.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Type (2015-2020)
2.3.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Type (2015-2020)
2.4 AI to Novel Coronavirus (COVID-19) and Epidemic Segment by Application
2.4.1 Medical
2.4.2 Public Emergency
2.4.3 Other
2.5 AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application
2.5.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Application (2015-2020)
2.5.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Application (2015-2020)
3 Global AI to Novel Coronavirus (COVID-19) and Epidemic by Players
3.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Players
3.1.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Players (2018-2020)
3.1.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Players (2018-2020)
3.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI to Novel Coronavirus (COVID-19) and Epidemic by Regions
4.1 AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Regions
4.2 Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth
4.3 APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth
4.4 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth
4.5 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth
5 Americas
5.1 Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Countries
5.2 Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type
5.3 Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Regions
6.2 APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type
6.3 APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe AI to Novel Coronavirus (COVID-19) and Epidemic by Countries
7.2 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type
7.3 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic by Countries
8.2 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type
8.3 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Forecast
10.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Forecast (2021-2025)
10.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecast by Regions
10.2.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecast by Type
10.8 Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecast by Application
11 Key Players Analysis
11.1 Google
11.1.1 Company Details
11.1.2 AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
11.1.3 Google AI to Novel Coronavirus (COVID-19) and Epidemic Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Google News
11.2 Iktos
11.2.1 Company Details
11.2.2 AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
11.2.3 Iktos AI to Novel Coronavirus (COVID-19) and Epidemic Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Iktos News
11.3 Alibaba
11.3.1 Company Details
11.3.2 AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
11.3.3 Alibaba AI to Novel Coronavirus (COVID-19) and Epidemic Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Alibaba News
11.4 BlueDot
11.4.1 Company Details
11.4.2 AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
11.4.3 BlueDot AI to Novel Coronavirus (COVID-19) and Epidemic Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 BlueDot News
11.5 Beijing Infervision Technology Co., Ltd.
11.5.1 Company Details
11.5.2 AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
11.5.3 Beijing Infervision Technology Co., Ltd. AI to Novel Coronavirus (COVID-19) and Epidemic Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Beijing Infervision Technology Co., Ltd. News
11.6 Artificial Intelligence in Medical Epidemiology
11.6.1 Company Details
11.6.2 AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
11.6.3 Artificial Intelligence in Medical Epidemiology AI to Novel Coronavirus (COVID-19) and Epidemic Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Artificial Intelligence in Medical Epidemiology News
11.7 Insilico Medicine
11.7.1 Company Details
11.7.2 AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
11.7.3 Insilico Medicine AI to Novel Coronavirus (COVID-19) and Epidemic Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Insilico Medicine News
11.8 BenevolentAI
11.8.1 Company Details
11.8.2 AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
11.8.3 BenevolentAI AI to Novel Coronavirus (COVID-19) and Epidemic Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 BenevolentAI News
11.9 DEARGEN
11.9.1 Company Details
11.9.2 AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
11.9.3 DEARGEN AI to Novel Coronavirus (COVID-19) and Epidemic Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 DEARGEN News
11.10 SenseTime
11.10.1 Company Details
11.10.2 AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
11.10.3 SenseTime AI to Novel Coronavirus (COVID-19) and Epidemic Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 SenseTime News
11.11 SRI Biosciences
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by AI to Novel Coronavirus (COVID-19) and Epidemic Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. AI to Novel Coronavirus (COVID-19) and Epidemic Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of AI Tracking
Table 7. Major Players of AI Predict
Table 8. Major Players of AI Recognition
Table 9. Major Players of Other
Table 10. AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type (2014-2019) ($ Millions)
Table 11. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Type (2015-2020)
Table 12. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application (2015-2020) ($ Millions)
Table 13. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Application (2015-2020)
Table 14. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue by Players (2018-2020) ($ Millions)
Table 15. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Players (2018-2020)
Table 16. Global AI to Novel Coronavirus (COVID-19) and Epidemic Key Players Head office and Products Offered
Table 17. AI to Novel Coronavirus (COVID-19) and Epidemic Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Regions 2015-2020 ($ Millions)
Table 21. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Regions 2015-2020
Table 22. Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Countries (2015-2020) ($ Millions)
Table 23. Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Countries (2015-2020)
Table 24. Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type (2015-2020) ($ Millions)
Table 25. Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Type (2015-2020)
Table 26. Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application (2015-2020) ($ Millions)
Table 27. Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Application (2015-2020)
Table 28. APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Regions (2015-2020) ($ Millions)
Table 29. APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Regions (2015-2020)
Table 30. APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type (2015-2020) ($ Millions)
Table 31. APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Type (2015-2020)
Table 32. APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application (2015-2020) ($ Millions)
Table 33. APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Application (2015-2020)
Table 34. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Countries (2015-2020) ($ Millions)
Table 35. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Countries (2015-2020)
Table 36. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type (2015-2020) ($ Millions)
Table 37. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Type (2015-2020)
Table 38. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application (2015-2020) ($ Millions)
Table 39. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Application (2015-2020)
Table 40. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Countries (2015-2020) ($ Millions)
Table 41. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Countries (2015-2020)
Table 42. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type (2015-2020) ($ Millions)
Table 43. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Type (2015-2020)
Table 44. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application (2015-2020) ($ Millions)
Table 45. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Application (2015-2020)
Table 46. Key and Potential Regions of AI to Novel Coronavirus (COVID-19) and Epidemic
Table 47. Key Application and Potential Industries of AI to Novel Coronavirus (COVID-19) and Epidemic
Table 48. Key Challenges of AI to Novel Coronavirus (COVID-19) and Epidemic
Table 49. Key Trends of AI to Novel Coronavirus (COVID-19) and Epidemic
Table 50. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 51. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share Forecast by Regions
Table 52. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Forecast by Type (2021-2025) ($ Millions)
Table 53. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share Forecast by Type (2021-2025)
Table 54. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Forecast by Application (2021-2025) ($ Millions)
Table 55. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share Forecast by Application (2021-2025)
Table 56. Google Details, Company Total Revenue (in $ million), Head Office, AI to Novel Coronavirus (COVID-19) and Epidemic Major Market Areas and Its Competitors
Table 57. Google AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
Table 58. Google AI to Novel Coronavirus (COVID-19) and Epidemic Revenue and Gross Margin (2018-2020E)
Table 59. Google Main Business
Table 60. Google Latest Developments
Table 61. Iktos Details, Company Total Revenue (in $ million), Head Office, AI to Novel Coronavirus (COVID-19) and Epidemic Major Market Areas and Its Competitors
Table 62. Iktos AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
Table 63. Iktos Main Business
Table 64. Iktos AI to Novel Coronavirus (COVID-19) and Epidemic Revenue and Gross Margin (2018-2020E)
Table 65. Iktos Latest Developments
Table 66. Alibaba Details, Company Total Revenue (in $ million), Head Office, AI to Novel Coronavirus (COVID-19) and Epidemic Major Market Areas and Its Competitors
Table 67. Alibaba AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
Table 68. Alibaba Main Business
Table 69. Alibaba AI to Novel Coronavirus (COVID-19) and Epidemic Revenue and Gross Margin (2018-2020E)
Table 70. Alibaba Latest Developments
Table 71. BlueDot Details, Company Total Revenue (in $ million), Head Office, AI to Novel Coronavirus (COVID-19) and Epidemic Major Market Areas and Its Competitors
Table 72. BlueDot AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
Table 73. BlueDot Main Business
Table 74. BlueDot AI to Novel Coronavirus (COVID-19) and Epidemic Revenue and Gross Margin (2018-2020E)
Table 75. BlueDot Latest Developments
Table 76. Beijing Infervision Technology Co., Ltd. Details, Company Total Revenue (in $ million), Head Office, AI to Novel Coronavirus (COVID-19) and Epidemic Major Market Areas and Its Competitors
Table 77. Beijing Infervision Technology Co., Ltd. AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
Table 78. Beijing Infervision Technology Co., Ltd. Main Business
Table 79. Beijing Infervision Technology Co., Ltd. AI to Novel Coronavirus (COVID-19) and Epidemic Revenue and Gross Margin (2018-2020E)
Table 80. Beijing Infervision Technology Co., Ltd. Latest Developments
Table 81. Artificial Intelligence in Medical Epidemiology Details, Company Total Revenue (in $ million), Head Office, AI to Novel Coronavirus (COVID-19) and Epidemic Major Market Areas and Its Competitors
Table 82. Artificial Intelligence in Medical Epidemiology AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
Table 83. Artificial Intelligence in Medical Epidemiology Main Business
Table 84. Artificial Intelligence in Medical Epidemiology AI to Novel Coronavirus (COVID-19) and Epidemic Revenue and Gross Margin (2018-2020E)
Table 85. Artificial Intelligence in Medical Epidemiology Latest Developments
Table 86. Insilico Medicine Details, Company Total Revenue (in $ million), Head Office, AI to Novel Coronavirus (COVID-19) and Epidemic Major Market Areas and Its Competitors
Table 87. Insilico Medicine AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
Table 88. Insilico Medicine Main Business
Table 89. Insilico Medicine AI to Novel Coronavirus (COVID-19) and Epidemic Revenue and Gross Margin (2018-2020E)
Table 90. Insilico Medicine Latest Developments
Table 91. BenevolentAI Details, Company Total Revenue (in $ million), Head Office, AI to Novel Coronavirus (COVID-19) and Epidemic Major Market Areas and Its Competitors
Table 92. BenevolentAI AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
Table 93. BenevolentAI Main Business
Table 94. BenevolentAI AI to Novel Coronavirus (COVID-19) and Epidemic Revenue and Gross Margin (2018-2020E)
Table 95. BenevolentAI Latest Developments
Table 96. DEARGEN Details, Company Total Revenue (in $ million), Head Office, AI to Novel Coronavirus (COVID-19) and Epidemic Major Market Areas and Its Competitors
Table 97. DEARGEN AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
Table 98. DEARGEN Main Business
Table 99. DEARGEN AI to Novel Coronavirus (COVID-19) and Epidemic Revenue and Gross Margin (2018-2020E)
Table 100. DEARGEN Latest Developments
Table 101. SenseTime Details, Company Total Revenue (in $ million), Head Office, AI to Novel Coronavirus (COVID-19) and Epidemic Major Market Areas and Its Competitors
Table 102. SenseTime AI to Novel Coronavirus (COVID-19) and Epidemic Product Offered
Table 103. SenseTime Main Business
Table 104. SenseTime AI to Novel Coronavirus (COVID-19) and Epidemic Revenue and Gross Margin (2018-2020E)
Table 105. SenseTime Latest Developments
Table 106. SRI Biosciences Details, Company Total Revenue (in $ million), Head Office, AI to Novel Coronavirus (COVID-19) and Epidemic Major Market Areas and Its Competitors
List of Figures
Figure 1. AI to Novel Coronavirus (COVID-19) and Epidemic Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Type (2015-2020)
Figure 5. Global AI Tracking Market Size Growth Rate
Figure 6. Global AI Predict Market Size Growth Rate
Figure 7. Global AI Recognition Market Size Growth Rate
Figure 8. Global Other Market Size Growth Rate
Figure 9. AI to Novel Coronavirus (COVID-19) and Epidemic in Medical
Figure 10. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market: Medical (2015-2020) ($ Millions)
Figure 11. AI to Novel Coronavirus (COVID-19) and Epidemic in Public Emergency
Figure 12. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market: Public Emergency (2015-2020) ($ Millions)
Figure 13. AI to Novel Coronavirus (COVID-19) and Epidemic in Other
Figure 14. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market: Other (2015-2020) ($ Millions)
Figure 15. Global Other YoY Growth ($ Millions)
Figure 16. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Application in 2019
Figure 17. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Regions 2015-2020
Figure 18. Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2015-2020 ($ Millions)
Figure 19. APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2015-2020 ($ Millions)
Figure 20. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2015-2020 ($ Millions)
Figure 21. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2015-2020 ($ Millions)
Figure 22. Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Countries in 2019
Figure 23. Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Type in 2019
Figure 24. Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Application in 2019
Figure 25. United States AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 26. Canada AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 27. Mexico AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 28. APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Regions in 2019
Figure 29. APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Type in 2019
Figure 30. APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Application in 2019
Figure 31. China AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 32. Japan AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 33. Korea AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 34. Southeast Asia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 35. India AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 36. Australia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 37. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Countries in 2019
Figure 38. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Type in 2019
Figure 39. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Application in 2019
Figure 40. Germany AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 41. France AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 42. UK AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 43. Italy AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 44. Russia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 45. Spain AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 46. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Countries in 2019
Figure 47. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Type in 2019
Figure 48. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Application in 2019
Figure 49. Egypt AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 50. South Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 51. Israel AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 52. Turkey AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 53. GCC Countries AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth 2015-2020 ($ Millions)
Figure 54. Global AI to Novel Coronavirus (COVID-19) and Epidemic arket Size Forecast (2021-2025) ($ Millions)
Figure 55. Americas AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 56. APAC AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 57. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 58. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 59. United States AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 60. Canada AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 61. Mexico AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 62. Brazil AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 63. China AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 64. Japan AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 65. Korea AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 66. Southeast Asia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 67. India AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 68. Australia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 69. Germany AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 70. France AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 71. UK AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 72. Italy AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 73. Russia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 74. Spain AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 75. Egypt AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 76. South Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 77. Israel AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 78. Turkey AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Figure 79. GCC Countries AI to Novel Coronavirus (COVID-19) and Epidemic Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets